Article
Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation - 1 Dec 2007
Azarpira Negar, Ramzi Mani, Aghdaie Mahdokht Hossein, Daraie Masumeh, Geramizadeh Bita
Abstract excerpt
OBJECTIVE: Methotrexate may be used as a prophylactic agent against graft-versus-host disease in hematopoietic cell transplant. The drug exerts its effect on folate metabolism; 5,10-methylenetetrahydrofolate reductase is a critical enzyme involved in this cycle and is related to the toxicity of methotrexate. METHODS: We examined the association of a single nucleotide polymorphism at position 677 in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
